Life sciences enterprises operate in an increasingly complex engagement landscape due to rising content fatigue, expanding Healthcare Professional (HCP)/patient touchpoints, and growing stakeholder expectations for relevance. Traditional engagement strategies, characterized by fragmented data, siloed operational workflows, and legacy technology systems built for function-level enablement, have led to disjointed engagement and effort duplicity across enterprise teams. Systems of Execution (SoE) address this challenge by acting as an intelligent execution layer that unifies data across commercial, medical affairs, and patient services to activate cross-functional synergies in delivering coordinated stakeholder-centric omnichannel engagement across the enterprise. By leveraging real-time data signals, AI-powered next-best-action recommendations, and automated adaptive engagement workflows, SoE enable enterprises to autonomously deliver personalized and contextually relevant stakeholder interactions with minimal human intervention. This report outlines core SoE capabilities and provides life sciences CXOs with a clear implementation roadmap. It helps life sciences CXOs achieve personalized, enterprise-scale omnichannel execution, designed to surface cross-functional insights and autonomously act on them, to deliver coordinated omnichannel engagement across enterprise functions.

Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience and achieve faster time-to-market. Providers are responding with targeted investments in AI / generative AI, data platforms, and industry-specific solutions to meet enterprise demands across the life sciences value chain. This PEAK Matrix® report offers a detailed evaluation of 35 providers delivering digital services in the life sciences sector, including biopharmaceutical, medical device, and others. It examines how these providers are enabling transformation through scalable solutions, co-innovation models, and differentiated capabilities. By assessing providers across dimensions such as market adoption, innovation, and delivery footprint, the report helps enterprise buyers identify the right strategic partners for their digital agendas. Scope Industry: life sciences (biopharmaceutical, medical devices, and others) Service: digital services Geography: global Contents In this report, we offer: Providers’ evaluations The evaluation scope Market trends Provider landscape analysis Key buyer considerations and takeaways Memberships Life Sciences Information Technology Sourcing and Vendor Management

Life sciences companies must engage customers effectively to drive business success through differentiated experiences. Hybrid commercial models require seamless, personalized interactions across channels to serve healthcare providers and patients. Advanced Customer Engagement Platforms (CEPs) go beyond traditional CRM systems to deliver real-time insights, dynamic content management, and omnichannel engagement. However, legacy systems, data silos, and fragmented customer experiences still pose challenges. To overcome these barriers, life sciences companies are partnering with specialized CEP providers to develop differentiated solutions that improve engagement, operational efficiency, and data-driven decision-making. In this research, we assess 27 providers featured on the Life Sciences CEP PEAK Matrix®. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other. Scope Industry: life sciences Geography: global The assessment is based on Everest Group’s annual RFI process for the calendar year 2024, interactions with leading life sciences CEP providers, client reference checks, and an ongoing analysis of the life sciences CEP market Contents In this report, we examine: The CEP provider landscape 27 life sciences CEP providers on several capability- and market success-related dimensions Memberships Life Sciences Information Technology Sourcing and Vendor Management

The life sciences industry is transforming significantly, driven by rapid technology advances and evolving customer expectations. In this dynamic landscape, commercial technology specialists are emerging as key players, offering innovative solutions across omnichannel engagement, intelligence, and content and learning management. These specialists are pivotal in helping life sciences companies navigate the modern market’s complexities, ensuring they remain competitive and relevant. In response, life sciences enterprises are increasingly turning to commercial technology specialists who bring a sophisticated understanding of advanced technologies such as AI, ML, and big data analytics, as well as expertise in a niche domain within the commercial technology value chain. These specialists are driving innovation by integrating these advanced capabilities into existing frameworks and developing new platforms that leverage a focused approach and also support cohesive commercial strategies. In this report, we assess specialists that offer proprietary life sciences commercial technology solutions, focusing on their core capabilities and market impact. We present an assessment and detailed profiles of trailblazers. Scope Industry: life sciences (biopharmaceuticals and medical devices) Geography: global Contents This report studies: Key trends shaping the life sciences commercial technology market Major adoption drivers for life sciences enterprises Enterprise-sourcing criteria for commercial technology Trailblazers, i.e., 23 leading life sciences commercial technology specialists Membership(s) Life Sciences Information Technology Life Sciences Commercial Technologies Sourcing and Vendor Management

Mid-market life sciences enterprises are increasingly transforming digitally to remain agile and resilient amid global uncertainties. They face unique challenges that differ from those of larger counterparts, necessitating sourcing needs such as client intimacy, agility, and cost-effective innovations to remain competitive. Recognizing these specific needs, providers are tailoring their strategies to offer personalized support and innovative solutions, capitalizing on the growing mid-market demand. Providers are investing in talent development and expanding their portfolios with comprehensive end-to-end solutions and bundled offerings. This approach delivers operational and cost efficiency, helping mid-market enterprises thrive in an increasingly digital landscape. In this report, we assess 26 providers featured on the Life Sciences Digital Services for Mid-market Enterprises PEAK Matrix® 2024. Each profile offers a comprehensive overview of the provider’s service focus, key intellectual property / solutions, domain investments, and case studies. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other. Scope Industry: life sciences (biopharmaceutical, medical devices, and others, including contract research organizations) Service: digital services Geography: global Contents In this report, we examine: Life sciences digital services market trends Providers’ capabilities, market success-related dimensions, and key strengths and limitations Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

Following the pandemic, industries began investing in personalized Customer Experience (CX) worldwide, including the life sciences commercial sector. To stay resilient and keep pace with the evolving landscape, the life sciences industry is adopting technology to differentiate for end-users. However, outdated tools and data fragmentation across business functions hinder enterprises from delivering personalized experiences. Currently, commercial technology in the life sciences industry primarily includes basic tools such as Customer Relationship Management (CRM) systems, content management systems, and marketing tools. These tools mainly serve as information repositories with limited insights into customers. Therefore, enterprises are enhancing these solutions with data analytics and AI/ML to develop customer-centric solutions that assist in targeted sales and effective messaging. This, in turn, boosts business performance and provides a competitive edge. Additionally, these solutions help internal stakeholders (such as IT departments, sales and marketing teams, and the medical affairs function) understand customer behavior and adapt their strategies accordingly. Scope: Industry: life sciences (biopharmaceuticals and medical devices) Geography: global Service: life sciences commercial technology Contents: In this report, we examine: Customer Experience Platforms (CXP) adoption market trends CXP adoption framework CXP landscape’s supplier ecosystem Implications for enterprises, service providers, and technology providers Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

Life sciences enterprises are recognizing the strategic importance of selecting the right service providers to enhance their competitive edge in an ever-evolving market. To achieve differentiation, enterprises are seeking partnerships that deliver tangible benefits, such as higher RoI, resilience amid challenging times, robust capabilities, and a distinct market positioning. Notably, enterprises have become more discerning in their partnerships and are seeking providers with a deep commitment to their successes and the credentials and capabilities to back their promises. This report examines the life sciences industry’s sourcing landscape and provides insights for service providers striving to align their offerings with the buyers’ needs and expectations in a dynamic market and amid tight regulatory pressures. Scope Industry: life sciences Geography: global Contents In this report, we examine: Life sciences enterprises’ provider selection criteria Life sciences enterprises’ investment priorities Key outsourcing drivers and challenges Life sciences enterprises’ extent of satisfaction with providers across dimensions Membership(s) Life Sciences Information Technology Life Sciences Business Process Sourcing and Vendor Management

The life science industry’s focus on driving improved customer experiences has steadily grown. Investments to improve customer experiences rank among the top priorities of life sciences enterprises. These enterprises must align customer engagement strategies with the preferences of all target customers to foster improved experiences. Before the pandemic, traditional methods dominated Healthcare Provider (HCP) engagement, but the pandemic accelerated digital channels’ role. Post-pandemic, the importance of digital channels persists alongside traditional approaches, as HCPs now prefer digital channels for specific activities, demanding a balanced engagement model. This evolution presents an opportunity for accessible and flexible engagement, requiring efficient resource allocation. A uniform approach does not suit all HCPs, highlighting the importance of the Hybrid Commercial Model (HCM). HCM optimizes resource allocation, improves insights, and elevates customer lifetime value by delivering tailored messages through suitable channels at optimal times. Addressing existing gaps in CRM technology stacks is vital for successful HCM adoption, as life sciences enterprises prioritize customer-centric approaches. This shift underscores HCM’s rapid adoption and its potential to enhance customer engagement in the life sciences sector. This report examines the rise of HCM in commercial HCP engagement, provides insights into associated challenges and benefits, explore the key tenets of HCM, discuss the significance of functionality enablers for HCM, and analyze the implications for commercial technology providers. Scope Industry: life sciences Geography: global Contents In this report, we examine: The rise of HCM Drivers, challenges, and benefits of HCM adoption Key tenets of HCM Key implications for commercial technology providers Membership(s) Life Sciences Information Technology Outsourcing Excellence

As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios, focusing on high-priority digital transformation initiatives, and seeking providers with specialized domain knowledge, agility, and life sciences-specific technical expertise. Additionally, niche providers are emerging in the post-pandemic era and gaining traction in the digital services market. This compendium provides detailed and fact-based snapshots of 16 life sciences digital service providers. Each profile offers a comprehensive picture of the provider’s offerings, technology solutions, key clients, recent developments, and investments. Scope Industry: life sciences Geography: global Contents This report features 16 life sciences digital service provider profiles and includes: Company overview: the company’s mission, client base, and revenue split across buyer segment and geographies Case studies demonstrating digital service provider capabilities Solutions/Products enabling digital service provider capabilities Recent product developments, partnerships, and investment areas Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

In recent years, the Healthcare and Life Sciences (HLS) industry has faced notable cyber threats, with the frequency of such incidents continuing to rise. These threats include targeted breaches of health records, patient databases, and pharmaceutical intellectual property. As a result, HLS enterprises are outsourcing cybersecurity solutions to providers that have a deep understanding of the industry. This is to comply with regulatory mandates, enhance patient/member data protection, safeguard enterprise reputation and trust, and secure medical devices. In this report, we explore significant cybersecurity themes in the HLS domain and identify highly adopted use cases, benefits, challenges, and emerging technologies and opportunities under each theme. The report will enable providers to invest strategically in cybersecurity, while guiding enterprises to formulate a robust cyber resilience strategy. Scope Industry: HLS Geography: global Contents In this report, we examine: Drivers and challenges of cybersecurity solutions Trends in the cybersecurity market Key cybersecurity service opportunities Cybersecurity solutions’ use cases for HLS enterprises Potential investment areas for providers Implications for enterprises Membership(s) Healthcare Payer and Provider Information Technology Cybersecurity Life Sciences Information Technology